Hyperplasia Therapy

Data on hyperplasia therapy discussed by researchers at National Taiwan University, Department of Dentistry

Published in Cancer Law Weekly, September 26th, 2009

Current study results from the report, 'Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications,' have been published. According to recent research from Taipei, Taiwan, "Oral verrucous hyperplasia (OVH) is a premalignant lesion that may transform into an oral cancer. Sixty consecutive OVH cases were collected from 2003 to 2004."

"Clinicopathological features and the 5-year malignant transformation rate of these 60 OVH lesions were evaluated and analyzed. We found that 84% of OVH lesions occurred in patients between 40 and 69 years of age. The most common site for OVH lesions was the buccal mucosa (48%), followed by the tongue (20%),...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Law Weekly

Source: Cancer Law Weekly (2009-09-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry